Targeting tumor O‐glycosylation modulates cancer–immune‐cell crosstalk and enhances anti‐<scp>PD</scp>‐1 immunotherapy in head and neck cancer
Mei‐Chun Lin(National Taiwan University Hospital), Pei‐Jen Lou(National Taiwan University Hospital)
Cited by 15